Company Statement: Genentech special committee of independent directors responds to Roche proposal
****************************************South San Francisco, Calif., 13 August 2008 - The special committee of the Board of Directors of Genentech, Inc. (NYSE: DNA) announced that, after careful consideration, it has unanimously concluded that...To view the full article, register now.
Already a subscriber? Click here to view full article